“Monolaurin is known to be effective against several lipid-coated viruses (a class which includes the AIDS virus), and against certain bacteria as well. Monolaurin works against lipid coated (enveloped) viruses much like AL 721 — an experimental AIDS treatment developed in Israel, and covered in depth in earlier articles in this series.”
Pengikut, Poskan Komentar, Monolaurin, Selasa, 01 Desember 2009.
“Recognition of the antimicrobial activity of monoglycerides of lauric acid (monolaurin) has been reported since 1966…at Michigan State University. The action attributed to monolaruin is that of solubilizing the lipids and phosolipids in the envelope of the (HIV) virus causing the disintegration of the virus envelope. In effect, it is reported that the fatty acids and monoglycerides produce their killing/inactivating effect by lysing the (lipid (bilayer) plasma membrane.”
Nutrients and Foods in Aids, edited by Ronald Watson, pg 81-83.
“(Using) lauric acid (C12:0) in its monoglyceride form (monolaurin or ML). The first clinical trial ever of ML was on 15 HIV-infected patients. Complete blood counts, blood lipids and tests for liver and kidney functions were done at the beginning of the study and after 3 and 6 months of treatment.
By the 3rd month, 7 of the patients (50%) showed reduced viral load and by the 6th month 8 patients had a lowered viral count. The two other AIDS patients were in the 2.4 g ML group; one recovered fully on the 6th month and the other showed a rapid return towards normal CD4 and CD8 counts.”
Conrado S. Dayrit, MD. FACC. FPCC. FPCP, Coconut oil in health and disease: its and monolaurin’s potential as cure for hiv/aids.
“Initial trials have confirmed that coconut oil does have an anti-viral effect and can beneficially reduce the viral load of HIV patients”.
Dr. Conrato S. Dayrit, Emeritus Professor of Pharmacology, University of the Philippines.
“Monolaurin, of which the precursor is lauric acid, disrupted the lipid membranes of envelope viruses and also inactivated bacteria, yeast and fungi. She wrote: “Of the saturated fatty acids, lauric acid has greater antiviral activity than either caprylic acid (C-10) or myristic acid (C-14). The action attributed to Monolaurin is that of solubilising the lipids ..in the envelope of the virus causing the disintegration of the (HIV) virus envelope.”
Mary G. Enig, Ph.D., F.A.C.N. “Coconut: In Support of Good Health in the 21st Century” Indian Coconut Journal, Sept., 1995.
“Lipids can inactivate enveloped viruses, bacteria, fungi, and protozoa. Medium chain length antiviral lipids can be added to human blood products that contain HIV-1 and HIV-2 and reduce the cell-free virus concentration by as much as 11 log10 TCID50/ml.”
Isaacs CE, Kim KS, Thormar H. Ann N Y Acad Sci. 1994 Jun 6;724:457-64. Department of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314. PMID: 8030973.
“Several new viral diseases occur as a result of changing climate, convenient and rapid transportation, and the raising of domesticated livestock which culminate in new strains of the viruses causing HIV/AIDS, SARS, and 2009 pandemic influenza that cannot be treated by the use of chemical drugs and antibiotics because they possess lipid coat that does not allow drugs to penetrate the viral particles, but surrender to the coconut oil, which, being lipid itself, could dissolve and break down their lipid coat, thereby penetrating them.”
Narong Chomchalow, Chairman, Conservation and Development of Coconut Oil of Thailand Forum, Bangkok, Thailand. Health and Economic Benefits of Coconut Oil Production Development.
“Monolaurin has statistically significant in vitro broad-spectrum sensitivity against Gram-positive and Gram-negative bacterial isolates from superficial skin infections. Most of the bacteria did not exhibit resistance to it.” (For accompaning illnesses)
Carpo, Beatriz G. Verallo-Rowell, Vermen M. Kabara, Jon, Novel antibacterial activity of monolaurin compared with conventional antibiotics against organisms from skin infections: an in vitro study.Journal of Drugs in Dermatology, 10/01/2007 Journal of Drugs in Dermatology, Inc. Audience: Academic; Date: Oct, 2007 Source Volume: 6 Source Issue: 10.